Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 229

Similar articles for PubMed (Select 20177381)

1.

Update on castrate-resistant prostate cancer: 2010.

Lassi K, Dawson NA.

Curr Opin Oncol. 2010 May;22(3):263-7. doi: 10.1097/CCO.0b013e3283380939.

PMID:
20177381
2.

Emerging therapies in castrate-resistant prostate cancer.

Lassi K, Dawson NA.

Curr Opin Oncol. 2009 May;21(3):260-5. doi: 10.1097/CCO.0b013e32832a1868. Review.

PMID:
19363343
3.

New therapies for castration-resistant prostate cancer: efficacy and safety.

Beltran H, Beer TM, Carducci MA, de Bono J, Gleave M, Hussain M, Kelly WK, Saad F, Sternberg C, Tagawa ST, Tannock IF.

Eur Urol. 2011 Aug;60(2):279-90. doi: 10.1016/j.eururo.2011.04.038. Epub 2011 May 4. Review.

PMID:
21592649
4.

Treatment options in hormone-refractory prostate cancer: current and future approaches.

Harris KA, Reese DM.

Drugs. 2001;61(15):2177-92. Review.

PMID:
11772129
5.

Recent advances in second-line treatment of castration-resistant prostate cancer.

Ong M, Winquist E.

Curr Opin Support Palliat Care. 2011 Sep;5(3):199-205. doi: 10.1097/SPC.0b013e32834903aa. Review.

PMID:
21734586
6.

New developments in castrate-resistant prostate cancer.

Shore N, Mason M, de Reijke TM.

BJU Int. 2012 Jun;109 Suppl 6:22-32. doi: 10.1111/j.1464-410X.2012.11217.x. Review.

PMID:
22672122
7.

Castrate-resistant prostate cancer: therapeutic strategies.

Harzstark AL, Small EJ.

Expert Opin Pharmacother. 2010 Apr;11(6):937-45. doi: 10.1517/14656561003677382. Review.

PMID:
20307219
8.

Updates on therapeutic targets and agents in castration-resistant prostate cancer.

Bishr M, Lattouf JB, Gannon PO, Saad F.

Minerva Urol Nefrol. 2011 Jun;63(2):131-43. Review.

PMID:
21623331
9.

Optimizing the care of patients with advanced prostate cancer in the UK: current challenges and future opportunities.

Payne H, Bahl A, Mason M, Troup J, De Bono J.

BJU Int. 2012 Sep;110(5):658-67. doi: 10.1111/j.1464-410X.2011.10886.x. Epub 2012 Mar 19.

PMID:
22429837
10.
11.

Therapies in development for castrate-resistant prostate cancer.

Harzstark AL, Ryan CJ.

Expert Rev Anticancer Ther. 2008 Feb;8(2):259-68. doi: 10.1586/14737140.8.2.259. Review.

PMID:
18279066
12.

[The treatment of castration-resistant prostate cancer].

Petrányi Á.

Magy Onkol. 2012 Dec;56(4):219-28. doi: MagyOnkol.2012.56.4.219. Epub 2012 Oct 3. Review. Hungarian.

13.

The evolving paradigm of second-line hormonal therapy options for castration-resistant prostate cancer.

Courtney KD, Taplin ME.

Curr Opin Oncol. 2012 May;24(3):272-7. doi: 10.1097/CCO.0b013e328351059d. Review.

PMID:
22327837
14.

Novel agents for the management of castration-resistant prostate cancer.

Haddad H, Garcia JA.

Curr Opin Urol. 2012 May;22(3):175-82. doi: 10.1097/MOU.0b013e3283523ba0. Review.

PMID:
22472509
15.

Changing therapeutic paradigms in castrate-resistant prostate cancer.

Zivi A, Massard C, De-Bono J.

Clin Genitourin Cancer. 2010 Dec 1;8(1):17-22. doi: 10.3816/CGC.2010.n.003. Review.

PMID:
21208851
16.

Zibotentan for the treatment of castrate-resistant prostate cancer.

Shepard DR, Dreicer R.

Expert Opin Investig Drugs. 2010 Jul;19(7):899-908. doi: 10.1517/13543784.2010.491822. Review.

PMID:
20497097
17.

Drug resistance in metastatic castration-resistant prostate cancer.

Seruga B, Ocana A, Tannock IF.

Nat Rev Clin Oncol. 2011 Jan;8(1):12-23. doi: 10.1038/nrclinonc.2010.136. Epub 2010 Sep 21. Review.

PMID:
20859283
18.

Abiraterone acetate, a novel adrenal inhibitor in metastatic castration-resistant prostate cancer.

Salem M, Garcia JA.

Curr Oncol Rep. 2011 Apr;13(2):92-6. doi: 10.1007/s11912-011-0153-4. Review.

PMID:
21243537
19.

New and emerging agents for the treatment of castration-resistant prostate cancer.

Higano CS, Crawford ED.

Urol Oncol. 2011 Nov-Dec;29(6 Suppl):S1-8. doi: 10.1016/j.urolonc.2011.08.013. Review.

PMID:
22074657
20.

Targeting continued androgen receptor signaling in prostate cancer.

Massard C, Fizazi K.

Clin Cancer Res. 2011 Jun 15;17(12):3876-83. doi: 10.1158/1078-0432.CCR-10-2815. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk